Case Studies: FDA Inspections of Indian Clinical Trial Sites
Case Studies: FDA Inspections of Indian Clinical Trial Sites What We Can Learn from FDA Inspections of Indian Clinical Trial Sites Introduction As India continues to position itself as a global hub for clinical research, the scrutiny of regulatory bodies—particularly the U.S. Food and Drug Administration (FDA)—has intensified. Indian clinical trial sites, including Contract Research…
Read More “Case Studies: FDA Inspections of Indian Clinical Trial Sites” »